ROCKET PHARMACEUTICALS, INC. (RCKT)
Rocket Pharmaceuticals, Inc., operating alongside its affiliates, is an innovative biotechnology enterprise dedicated to pioneering gene therapies for rare and severely debilitating diseases. The company's active clinical pipeline features multiple promising programs. It is currently progressing three ex vivo lentiviral vector therapies aimed at specific genetic conditions: Fanconi anemia, characterized by a bone marrow defect that hinders blood cell production; leukocyte adhesion deficiency-I, an inherited disorder resulting in a compromised immune system; and pyruvate kinase deficiency, a rare autosomal recessive red blood cell ailment leading to chronic non-spherocytic hemolytic anemia. Complementing these, Rocket Pharmaceuticals also has an in vivo adeno-associated virus program underway for Danon disease, a serious multi-organ lysosomal storage disorder that tragically often results in early mortality due to heart failure. To facilitate its extensive research and development efforts, the company has established key licensing partnerships with esteemed institutions such as the Fred Hutchinson Cancer Research Center, European research bodies including CIEMAT and its collaborators (Centro de Investigacion Biomedica En Red and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz), UCL Business PLC (in conjunction with CIEMAT), The Regents of the University of California, and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. maintains its primary corporate location in Cranbury, New Jersey.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Rocket Pharmaceuticals, Inc.
No splits on record
Nothing in RCKT's public trading history: no forward or reverse split has affected the share count.
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $11.03M | $0 | $0 | $0 | $0 | $1.15M | $426K | $330K | $204K | $169K | $45K | $0 | $0 | $0 |
| Gross Profit | -$11.03M | $0 | $0 | $0 | $0 | -$1.15M | -$426K | -$330K | -$204K | -$169K | -$45K | $0 | $0 | $0 |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research and Development | $142.01M | $171.24M | $186.34M | $165.57M | $125.48M | $106.38M | $58.62M | $53.27M | $14.19M | $31.98M | $12.55M | $5.59M | $5.33M | $3.54M |
| Selling, General, and Administrative | $86.5M | $101.96M | $73.32M | $58.77M | $41.77M | $27.92M | $17.53M | $17.89M | $12.54M | $9.89M | $7.84M | $2.11M | $1.32M | $2.31M |
| Other | -$11.03M | $0 | $0 | $0 | $0 | $0 | -$250K | -$186K | $0 | $0 | $0 | $0 | $3K | $4K |
| Total Operating Expenses | $217.49M | $273.2M | $259.66M | $224.34M | $167.25M | $134.86M | $75.9M | $70.97M | $26.74M | $41.88M | $20.4M | $7.7M | $6.65M | $5.85M |
| Operating Income (EBIT) | -$228.52M | -$273.2M | -$259.66M | -$224.34M | -$167.25M | -$136M | -$76.15M | -$71.16M | -$26.74M | -$41.88M | -$20.4M | -$7.7M | -$6.65M | -$5.85M |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $1.89M | $1.89M | $1.88M | $1.91M | $5.89M | $7.55M | $4.78M | $5.24M | $3.58M | $1.42M | $1.23M | $980K | $884K | $213K |
| Interest Income | $10.62M | $18.22M | $15.94M | $3.89M | $3.07M | $2.15M | $3.41M | $1.69M | $819K | $443K | $89K | $0 | $0 | $0 |
| Other Income (Expense) | $5.39M | $14.46M | $14.06M | $2.48M | -$1.82M | -$3.7M | -$1.12M | -$3.36M | -$2.76M | -$975K | -$47.59M | -$1.83M | -$962K | -$209K |
| Income Before Tax (EBT) | -$223.12M | -$258.75M | -$245.59M | -$221.86M | -$169.07M | -$139.7M | -$77.27M | -$74.52M | -$29.5M | -$42.85M | -$67.98M | -$9.53M | -$7.62M | -$6.06M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $6.97M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$223.12M | -$258.75M | -$245.59M | -$221.86M | -$169.07M | -$146.67M | -$83.23M | -$74.52M | -$29.5M | -$42.85M | -$67.98M | -$9.53M | -$7.62M | -$6.06M |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Supplementary Data | ||||||||||||||
| EPS | -2.01 | -2.73 | -2.92 | -3.26 | -2.68 | -2.52 | -1.70 | -1.89 | -4.36 | -6.41 | -10.29 | -4.53 | -3.62 | -2.88 |
| Diluted EPS | -2.01 | -2.73 | -2.92 | -3.26 | -2.68 | -2.52 | -1.70 | -1.89 | -4.36 | -6.41 | -14.85 | -4.53 | -3.62 | -2.88 |
| Weighted Average OS | 111.12M | 94.81M | 84.01M | 68.15M | 63.24M | 55.38M | 49.01M | 39.38M | 6.77M | 6.68M | 6.61M | 2.10M | 2.10M | 2.10M |
| EBITDA | -$210.21M | -$247.49M | -$236.62M | -$213.69M | -$157.81M | -$131.59M | -$71.14M | -$71.16M | -$20.01M | -$41.27M | -$20.26M | -$7.7M | -$6.73M | -$5.84M |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash and Cash Equivalents | $77.56M | $163.63M | $55.9M | $140.52M | $232.69M | $297.1M | $185.38M | $111.36M | $78.72M | $29.8M | $80.04M | $3.62M | $12.79M | $1.37M |
| Short-Term Investments | $111.37M | $208.7M | $317.27M | $215.88M | $156.05M | $185.62M | $118.73M | $94.38M | $21.29M | $96.67M | $31.24M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $188.93M | $372.34M | $373.18M | $356.39M | $388.74M | $482.72M | $304.12M | $205.73M | $100.01M | $126.47M | $111.28M | $3.62M | $12.79M | $1.37M |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $3.81M | $5.85M | $5.05M | $7.67M | $0 | $0 | $0 | $3.36M | $0 | $0 | $0 | $52K | $0 | $0 |
| Total Current Assets | $192.73M | $378.18M | $378.22M | $364.06M | $392.06M | $487.35M | $307.75M | $209.09M | $101.05M | $128.35M | $112.37M | $3.62M | $12.86M | $1.42M |
| Long-Term Assets | ||||||||||||||
| Property, Plant & Equipment Net | $71.59M | $83.32M | $87.59M | $77.64M | $72.35M | $70.64M | $31.35M | $2.03M | $563K | $1.13M | $812K | $0 | $0 | $0 |
| Goodwill | $39.15M | $39.15M | $39.15M | $39.15M | $30.82M | $30.82M | $30.82M | $30.82M | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $25.15M | $25.15M | $25.15M | $25.72M | $0 | $0 | $226K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1.34M | $0 | $34.32M | $43.28M | $0 | $0 | $1.52M | $7.4M | $207K | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | -$1.57M | -$1.52M | $545K | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $482K | $1.89M | $1.91M | $1.95M | $1.8M | $3.59M | $1.98M | $1.44M | -$39K | $168K | $143K | $1.9M | $4K | $4K |
| Total Long-Term Assets | $137.72M | $149.52M | $188.12M | $187.75M | $104.96M | $103.48M | $64.37M | $42.23M | $731K | $1.3M | $955K | $1.9M | $4K | $4K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $330.45M | $527.7M | $566.34M | $551.81M | $497.02M | $590.82M | $372.12M | $251.31M | $101.78M | $129.65M | $113.32M | $5.52M | $12.86M | $1.42M |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payable | $0 | $1.63M | $0 | $0 | $0 | $0 | $0 | $0 | $451K | $1.59M | $1.63M | $1.15M | $229K | $387K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $4.88M | $0 | $0 | $0 | $0 | $0 | $5.08M | $1.41M | $2.71M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $590K | $562K | $534K | $506K | $478K | $450K | $421K | $394K | $367K |
| Other Current Liabilities | $12.29M | $185K | $9.93M | $10.01M | $4.53M | $2M | $13.64M | $12.93M | $557K | $2.97M | $549K | -$3.24M | $468K | -$207K |
| Total Current Liabilities | $30.21M | $40.68M | $48.51M | $39.17M | $22.17M | $32.62M | $18.31M | $15.37M | $4.07M | $7.21M | $4.14M | $3.7M | $3.22M | $3.77M |
| Long-Term Liabilities | ||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $35.07M | $45.05M | $41.45M | $49.54M | $48.96M | $0 | $2.55M | $5.39M | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $1.06M | $1.14M | $2.94M | $2.6M | $80K | $136K | $23K | $457K | $403K | $307K | $367K | $50.83M | $43.15M | $28.59M |
| Total Long-Term Liabilities | $23.02M | $23.78M | $25.26M | $22.95M | $20.13M | $54.69M | $46.52M | $41.9M | $49.94M | $49.27M | $367K | $53.38M | $48.54M | $28.59M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $53.23M | $64.47M | $73.77M | $62.12M | $42.3M | $87.31M | $64.82M | $57.28M | $54.01M | $56.48M | $4.51M | $57.08M | $51.76M | $32.35M |
| Stockholders' Equity | ||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $41.47M | $16K | $0 | $46.8M | $41.23M | $28.56M |
| Common Stock | $1.08M | $1.06M | $903K | $791K | $645K | $610K | $548K | $452K | $68K | $270K | $264K | $10K | $10K | $10K |
| Retained Earnings | -$1.44B | -$1.22B | -$959.37M | -$713.77M | -$491.91M | -$322.84M | -$183.14M | -$105.87M | -$268.37M | -$238.88M | -$196.02M | -$128.04M | -$118.51M | -$110.89M |
| Comprehensive Income & Other | -$31K | $66K | $319K | -$357K | -$161K | -$42K | $20K | -$127K | -$16K | -$54K | -$11K | -$217K | -$217K | -$217K |
| Other Stockholders' Equity | $1.72B | $1.68B | $1.45B | $1.2B | $945.99M | $825.75M | $489.89M | $299.46M | $316.07M | $311.77M | $304.57M | $76.47M | $79.61M | $79.95M |
| Total Equity | $277.22M | $463.23M | $492.57M | $489.69M | $454.72M | $503.52M | $307.3M | $194.04M | $47.76M | $73.17M | $108.81M | -$51.56M | -$38.9M | -$30.93M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $330.45M | $527.7M | $566.34M | $551.81M | $497.02M | $590.82M | $372.12M | $251.31M | $101.78M | $129.65M | $113.32M | $5.52M | $12.86M | $1.42M |
| Supplementary Data | ||||||||||||||
| Total Debt | $24.88M | $25.5M | $25.04M | $22.87M | $22.6M | $61.7M | $47.45M | $41.45M | $49.54M | $48.96M | $0 | $7.15M | $6.8M | $2.71M |
| Net Debt | -$52.68M | -$138.14M | -$30.86M | -$117.65M | -$210.09M | -$235.4M | -$137.93M | -$69.91M | -$29.18M | $19.16M | -$80.04M | $3.54M | -$5.99M | $1.34M |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Operating Activities | ||||||||||||||
| Net Income | -$223.12M | -$258.75M | -$245.59M | -$221.86M | -$169.07M | -$139.7M | -$77.27M | -$74.52M | -$29.5M | -$42.85M | -$67.98M | -$9.53M | -$7.62M | -$6.06M |
| Depreciation & Amortization | $11.03M | $9.38M | $7.1M | $6.27M | $5.37M | $1.15M | $426K | $330K | $200K | $169K | $45K | $0 | $0 | $9K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $3.15M | $999K | -$1.07M | -$484K | $654K | $225K | $46.36M | $0 | $0 | $2K |
| Stock-Based Compensation | $37.06M | $43.92M | $39.41M | $31.01M | $29.24M | $18.57M | $13.37M | $13.6M | $4.04M | $2.91M | $2.38M | $177K | -$148K | $486K |
| Changes in Working Capital: | ||||||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $0 | $0 | $0 | $9.67M | -$4.83M | $11.02M | -$2.72M | $5.89M | -$1.14M | -$41K | $487K | $917K | -$158K | $159K |
| Other Working Capital | -$8.3M | $1.92M | $13.46M | -$3.6M | $1.44M | $4.01M | -$1M | -$1.5M | -$886K | $2.16M | $182K | -$2.39M | $894K | -$1.75M |
| Total Working Capital Change | -$8.3M | $1.92M | $13.46M | $6.08M | -$3.39M | $15.03M | -$3.73M | $4.38M | -$2.03M | $2.12M | $669K | -$1.47M | $736K | -$1.59M |
| Other Non-Cash Items | -$6.68M | -$6.19M | -$9.28M | $370K | $13.53M | $29.32M | $3.6M | $2.9M | $522K | $162K | $1.11M | $1.08M | $573K | $213K |
| Net Cash from Operating | -$190.01M | -$209.72M | -$194.92M | -$178.14M | -$121.16M | -$74.64M | -$64.66M | -$53.79M | -$26.11M | -$37.27M | -$17.42M | -$9.74M | -$6.46M | -$6.94M |
| Investing Activities | ||||||||||||||
| Capital Expenditures | -$440K | -$5.86M | -$16.47M | -$8.62M | -$7.71M | -$29.06M | -$23.27M | -$1.45M | -$70K | -$487K | -$412K | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $42.73M | $95K | $8.45M | $16K | $76.35M | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$276.55M | -$245.89M | -$390.92M | -$376.33M | -$245.88M | -$209.34M | -$184.3M | -$141.09M | -$27.2M | -$122.28M | -$33.69M | $0 | $0 | $0 |
| Sales of Investments | $380.76M | $383.45M | $309.33M | $272.89M | $272.44M | $141.81M | $168.56M | $61.28M | $102.29M | $56.7M | $2.43M | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | -$95K | -$8.45M | -$16K | -$356K | $0 | $0 | $0 | $0 | $0 | $3K |
| Net Cash from Investing | $103.77M | $131.71M | -$98.07M | -$69.33M | $18.85M | -$96.59M | -$39.01M | -$5.27M | $75.02M | -$66.06M | -$31.68M | $0 | $0 | $3K |
| Financing Activities | ||||||||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | - | -$48.74M | -$13.36M | -$560K | -$7.92M | -$2.5M |
| Common Stock Issuance | $0 | $185.74M | $208.39M | $155.34M | $37.68M | $281.35M | $178.1M | $154.02M | $35K | $4M | $112.05M | $0 | $0 | $0 |
| Common Stock Repurchases | -$67K | $0 | $0 | -$47K | $0 | -$72K | $0 | -$668K | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $215K | $0 | -$132K | -$172K | -$201K | -$3.85M | -$313K | $148K | $19K | $346K | $106K | $8K | $0 | $0 |
| Net Cash from Financing | $148K | $185.74M | $208.4M | $155.29M | $37.68M | $282.99M | $177.79M | $153.5M | $25K | $16 | $125.52M | $568K | $17.88M | $2.5M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$86.1M | $107.72M | -$84.58M | -$92.18M | -$64.63M | $111.76M | $74.12M | $94.44M | $48.92M | -$50.24M | $76.42M | -$9.18M | $11.42M | -$4.43M |
| Supplementary Data | ||||||||||||||
| Operating Cash Flow | -$190.01M | -$209.72M | -$194.92M | -$178.14M | -$121.16M | -$74.64M | -$64.66M | -$53.79M | -$26.11M | -$37.27M | -$17.42M | -$9.74M | -$6.46M | -$6.94M |
| Capital Expenditure | -$440K | -$5.86M | -$16.47M | -$8.62M | -$7.71M | -$29.06M | -$23.27M | -$1.45M | -$70K | -$487K | -$412K | $0 | $0 | $0 |
| Free Cash Flow | -$190.45M | -$215.59M | -$211.39M | -$186.76M | -$128.88M | -$103.7M | -$87.93M | -$55.24M | -$26.18M | -$37.75M | -$17.83M | -$9.74M | -$6.46M | -$6.94M |
| Cash at Beginning | $165M | $57.28M | $141.86M | $234.04M | $298.67M | $186.91M | $112.79M | $18.35M | $29.8M | $80.04M | $3.62M | $12.79M | $1.37M | $5.8M |
| Cash at End | $78.9M | $165M | $57.28M | $141.86M | $234.04M | $298.67M | $186.91M | $112.79M | $78.72M | $29.8M | $80.04M | $3.62M | $12.79M | $1.37M |